Industry: Healthcare
Investor: U.S. Venture Capital
Invested: January 2012
Company description: GenomeDx Biosciences Inc. is a personalized medicine company focused on the development and commercialization of genomic based diagnostic and prognostic tools that analyze the biology of cancer to improve the treatment decision-making process by recognizing the importance of each patient’s unique set of genetic information.